About 1,188 results

ALLMedicine™ Pancreas Transplantation Center

Research & Reviews  430 results

Hematochezia: A late complication after pancreas transplantation.
American Journal of Transplantation : Official Journal Of... Zatorski C, Liu PT et. al.

Dec 2nd, 2021 - Hematochezia: A late complication after pancreas transplantation.|2021|Zatorski C,Liu PT,Moritz MJ,Du C,|

Letermovir treatment for CMV infection in kidney and pancreas transplantation: a valuab...
Clinical Transplantation; Ortiz F, Lempinen M et. al.

Nov 20th, 2021 - Cytomegalovirus (CMV) infection remains a major challenge in solid organ transplantation. Ganciclovir has changed the prognosis, but with the expense of possible viral resistance. New antiviral drugs, such as letermovir, have not been studied suff...

Impact of Anti-HLA De Novo Donor Specific Antibody on Graft Outcomes in Pancreas Transp...
Transplantation Proceedings; Khan SM, Sumbal R et. al.

Nov 14th, 2021 - The aim of this review is to provide consensus on the impact of antihuman leukocyte antigen (anti-HLA) de novo donor-specific antibodies (dnDSA) on pancreatic allograft loss. We systematically searched electronic databases through August 2020 usin...

Pancreas transplantation.
Nephrology, Dialysis, Transplantation : Official Publicat... Sutherland A, Marson L

Nov 10th, 2021 - Pancreas transplantation.|2021|Sutherland A,Marson L,|

see more →

Clinicaltrials.gov  18 results

Role of Pancreatic Exocrine Secretion in Weight Gain After Pancreas Transplantation

Sep 21st, 2021 - Pancreas transplantation is currently the most reliable method for glycemic control in insulin dependent diabetic patients. Outcomes of pancreas transplantation have improved significantly over the years due to improved surgical techniques, medica...

Safety and Effectiveness of NRP for DCD Heart Transplantation

Sep 1st, 2021 - The current procedure of DCD organ donation and procurement follows a well-established course for lung, liver, kidney and pancreas transplantation in the United States. DCD transplantation of a heart has been hampered due to concern about the graf...

Sirolimus vs Mycophenolate With Tacrolimus in Simultaneous Pancreas and Kidney Transplantation

Apr 26th, 2021 - MTOR (mammalian target of rapamycin) inhibitors represent group of immunosuppressive drugs with mechanism of T-cell blockade complementary to calcineurin inhibitors. The investigators presume that combination of sirolimus with tacrolimus will resu...

Reparixin in Pancreatic Islet Transplantation

Mar 11th, 2021 - Pancreatic islet transplantation has become a feasible option in the treatment of T1D which offers advantages over whole pancreas transplantation. However to date insulin independence can be obtained in most cases only after the patient has receiv...

Heart Transplantation Using Normothermic Regional Perfusion Donation After Circulatory Death

Jan 27th, 2021 - The current procedure of DCD organ donation and procurement follows a well-established course for lung, liver, kidney and pancreas transplantation in the United States. After consent has been obtained, the organs are allocated through UNOS. When a...

see more →

News  27 results

FDA Panel: Pancreatic Islet Transplant Should Be Option for T1D

Apr 16th, 2021 - An FDA advisory committee agreed that cadaveric allogeneic pancreatic islet cells (donislecel) for treating brittle type 1 diabetes is worth the risks for certain patients. In a 12-4 vote Thursday with one abstention, members of the Cellular, Tiss...

Liver Cancer: New Prognostic Tool for Liver Transplant Patients

Jan 22nd, 2015 - A tool that offers a better way to predict risk for liver cancer recurrence after liver transplantation has been developed by researchers at the University of California, Los Angeles (UCLA). It is based on results from an analysis of 30 years' wor...

Diabetes Survival Improved With Pancreas-Kidney Transplant

Oct 16th, 2012 - October 16, 2012 (Berlin, Germany) — Simultaneous pancreas-kidney (SPK) transplantation provides better long-term patient survival compared with single kidney transplantation alone for patients with type 1 diabetes (T1DM) and end-stage renal disea...

Belatacept -- A Welcome New Transplantation Drug

Jun 20th, 2011 - Jeffrey S. Berns, MD: Hello. This is Jeffrey Berns from the University of Pennsylvania School of Medicine in Philadelphia. I'm Editor-in-Chief of Medscape Nephrology. I am here with Dr. Roy Bloom, who is our Medical Director for Kidney and Pancrea...

Extended CMV Prophylaxis After Kidney, Pancreas Transplants Lowers Risk, Costs

Sep 17th, 2009 - September 17, 2009 — Increasing the period of preventive treatment with valganciclovir from 3 to 6 months after kidney and/or pancreas transplantation can reduce the risk for cytomegalovirus (CMV) disease, leading to significant overall cost savin...

see more →